Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival. (February 2019) - Mazza, S.; Invernizzi, F.; Iavarone, M.; Zavaglia, C.; Maggi, U.; Cesarini, L.; Antonelli, B.; Airoldi, A.; Manini, M.A.; Sangiovanni, A.; Rossi, G.; Donato, M.F.; et al.